142 related articles for article (PubMed ID: 8997576)
1. Ciprofloxacin ophthalmic solution in the treatment of conjunctivitis and blepharitis: a comparison with fusidic acid.
Adenis JP; Colin J; Verin P; Riss I; Saint-Blancat P
Eur J Ophthalmol; 1996; 6(4):368-74. PubMed ID: 8997576
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
Adenis JP; Colin J; Verin P; Saint-Blancat P; Malet F
Eur J Ophthalmol; 1995; 5(2):82-7. PubMed ID: 7549447
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
Adenis JP; Brasseur G; Demailly P; Malet F; Verin P; Saint-Blancat P; Retout A; Ollé P; Colin J
Eur J Ophthalmol; 1996; 6(3):287-92. PubMed ID: 8908436
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
Shulman DG; Sargent JB; Stewart RH; Mester U
Eur J Ophthalmol; 1996; 6(4):361-7. PubMed ID: 8997575
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol.
Power WJ; Collum LM; Easty DL; Bloom PA; Laidlaw DA; Libert J; Sangers D; Wuokko M; Saksela T
Eur J Ophthalmol; 1993; 3(2):77-82. PubMed ID: 8353434
[TBL] [Abstract][Full Text] [Related]
6. Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis.
Malminiemi K; Kari O; Latvala ML; Voutilainen R; Miettinen A; Jauch A
Acta Ophthalmol Scand; 1996 Jun; 74(3):280-4. PubMed ID: 8828727
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
8. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.
Bloom PA; Leeming JP; Power W; Laidlaw DA; Collum LM; Easty DL
Eur J Ophthalmol; 1994; 4(1):6-12. PubMed ID: 8019124
[TBL] [Abstract][Full Text] [Related]
9. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
Everett SL; Kowalski RP; Karenchak LM; Landsittel D; Day R; Gordon YJ
Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
[TBL] [Abstract][Full Text] [Related]
10. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
Friedlaender MH
CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
[TBL] [Abstract][Full Text] [Related]
11. [Clinical efficacy of ciprofloxacin 0.3%9 (Ciloxan) in the treatment of bacterial infections of the external eye segment].
Stankiewicz A; Kosatka M; Goś A
Klin Oczna; 2003; 105(6):407-9. PubMed ID: 15049266
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
[TBL] [Abstract][Full Text] [Related]
13. Effect of ciprofloxacin and ofloxacin on bacterial flora.
Wittpenn JR
J Cataract Refract Surg; 2001 Aug; 27(8):1144-6. PubMed ID: 11530786
[No Abstract] [Full Text] [Related]
14. Efficacy of norfloxacin in bacterial conjunctivitis.
Huber-Spitzy V; Arocker-Mettinger E; Baumgartner I
Eur J Ophthalmol; 1991; 1(2):69-72. PubMed ID: 1821203
[TBL] [Abstract][Full Text] [Related]
15. Effect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctiva.
Snyder-Perlmutter LS; Katz HR; Melia M
J Cataract Refract Surg; 2000 Nov; 26(11):1620-5. PubMed ID: 11084269
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections.
Jacobson JA; Call NB; Kasworm EM; Dirks MS; Turner RB
Antimicrob Agents Chemother; 1988 Dec; 32(12):1820-4. PubMed ID: 3072923
[TBL] [Abstract][Full Text] [Related]
17. Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops.
Hvidberg J
Acta Ophthalmol (Copenh); 1987 Feb; 65(1):43-7. PubMed ID: 3554881
[TBL] [Abstract][Full Text] [Related]
18. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
20. Fusidic acid in infections of the external eye.
van Bijsterveld OP; el Batawi Y; Sobhi FS; Nassar MW
Infection; 1987; 15(1):16-9. PubMed ID: 3570479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
